in 1998, a group of young women, all diagnosed with breast cancer before age 40, gathered in new york city and had the first ysc meeting.
verzenio (abemaciclib) is a treatment for both hr+, her2-, high risk, node positive early breast cancer and for certain types of hr+, her2- metastatic breast cancer.
youngsurvival.org Top 5 competitors are verzenio.com